These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4419502)

  • 1. Proceedings: Vaginal cytologic evaluation as a predictive test on hormone dependency and responsiveness to progestogens of endometrial adenocarcinoma.
    Ide P; Bonte J
    Br J Cancer; 1974 Aug; 30(2):175. PubMed ID: 4419502
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaginal cytologic evaluation as a practical link between hormone blood levels and tumor hormone dependency in exclusive medroxyprogesterone treatment of recurrent or metastatic endometrial adenocarcinoma.
    Bonte J; Decoster JM; Ide P
    Acta Cytol; 1977; 21(2):218-24. PubMed ID: 266331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytologic evaluation of exclusive medroxyprogesterone acetate treatment for vaginal recurrence of endometrial adenocarcinoma.
    Bonte J; Drochmans A; Ide P
    Acta Cytol; 1970 May; 14(5):353-6. PubMed ID: 5284269
    [No Abstract]   [Full Text] [Related]  

  • 4. Progestins in the treatment of endometrial carcinoma.
    Anderson DG
    Surg Forum; 1965; 16():398-400. PubMed ID: 5835208
    [No Abstract]   [Full Text] [Related]  

  • 5. Progestins in the treatment of patients with endometrial adenocarcinoma.
    Smith JP; Rutledge F; Soffar SW
    Am J Obstet Gynecol; 1966 Apr; 94(7):977-84. PubMed ID: 5910365
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of in vivo and in vitro responses of endometrial adenocarcinoma to progestins.
    Holinka CF; Deligdisch L; Deppe G; Fleming H; Namit C; de la Pena MM; Gurpide E
    Adv Exp Med Biol; 1981; 138():365-76. PubMed ID: 6211063
    [No Abstract]   [Full Text] [Related]  

  • 7. The endometrial adenocarcinoma as a model for hormone-dependency and hormone-responsiveness of gynaecological cancers.
    Bonte J
    Eur J Obstet Gynecol Reprod Biol; 1984 Dec; 18(5-6):335-41. PubMed ID: 6526120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medroxyprogesterone and endometrial adenocarcinoma].
    Serment H; Spitalier JM; Ayme Y; Degiovanni E; Bardin JP
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(1):93-7. PubMed ID: 5453572
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of adenocarcinoma of the endometrium with synthetic progestogens].
    Lanza A; Fedele M; Renzetti ME; Ferraris G
    Minerva Ginecol; 1981 Oct; 33(10):917-36. PubMed ID: 7031519
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progestins in combined treatment of endometrial cancer].
    Voznyĭ EK; Titova VA
    Sov Med; 1990; (9):102-7. PubMed ID: 2148437
    [No Abstract]   [Full Text] [Related]  

  • 11. Progestogens in the treatment of carcinoma of the endometrium.
    Kennedy BJ
    Surg Gynecol Obstet; 1968 Jul; 127(1):103-14. PubMed ID: 5657772
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of progestogen therapy with the conventional treatment of endometrial carcinoma.
    Luukkainen T; Karjalainen O
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):581-5. PubMed ID: 5510182
    [No Abstract]   [Full Text] [Related]  

  • 13. The possible mechanisms of action of progestins on endometrial adenocarcinoma.
    Anderson DG
    Am J Obstet Gynecol; 1972 May; 113(2):195-211. PubMed ID: 4112650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal treatment of recurrent endometrial carcinoma. Report of a case.
    Nilsen PA
    J Obstet Gynaecol Br Commonw; 1968 Jan; 75(1):99-100. PubMed ID: 5635249
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormonoprophylaxis and hormonotherapy in the treatment of endometrial adenocarcinoma by means of medroxyprogesterone acetate.
    Bonte J; Decoster JM; Ide P; Billiet G
    Gynecol Oncol; 1978 Feb; 6(1):60-75. PubMed ID: 620950
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hormone therapy in advanced forms of carcinoma of the endometrium: analysis and prospects].
    La Vecchia C; Franceschi S; Gritti P; Valente I
    Ann Ostet Ginecol Med Perinat; 1980; 101(3):181-6. PubMed ID: 7006487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
    Cohen CJ; Deppe G; Bruckner HW
    Obstet Gynecol; 1977 Oct; 50(4):415-7. PubMed ID: 904803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MAP in the treatment of adenocarcinoma of the endometrium].
    Leone F; De Placido G; Frollo G
    Minerva Ginecol; 1979 Apr; 31(4):251-5. PubMed ID: 460664
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of metastasizing carcinoma of the uterus with gestagens].
    Engeler V
    Schweiz Med Wochenschr; 1971 Dec; 101(52):1906-9. PubMed ID: 5141283
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the mechanism of action of a progestin on endometrial andenocarcinoma.
    Anderson DG
    Surg Forum; 1969; 20():411-3. PubMed ID: 5376941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.